PLUS1
1,650.40
46.40 (2.89%)
46.40 (2.89%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Glaxosmithkline Plc | GSK | London | Ordinary Share | GB0009252882 | ORD 25P |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 46.40 | 2.89% | 1,650.40 | 1,620.40 | 1,656.20 | 1,628.60 | 1,604.00 | 11:35:11 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1,654.20 | 1,654.60 | 0.40 | 0.02% | 2 | 8 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,575 | 7,804,653 | 1,644.47p | 128,345,419p | - | 1,328.60 - 1,857.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:28:24 | O | 3,025 | 1,624.279p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0.00p | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Glaxosmithkline News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/15/2020 | 08:00 | Dow Jones News | Orchard in License Agreements for Stable Cell Line.. |
| 7/15/2020 | 04:31 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 7/15/2020 | 02:47 | Dow Jones News | GlaxoSmithKline's Belantamab Mafodotin Gets Recommendation.. |
| 7/15/2020 | 02:00 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC FDA Panel Votes IN FAVOR of Belantamab.. |
| 7/15/2020 | 01:31 | Alliance News |  GSK's Belantamab Gets US Committee Nod But Awaiting FDA.. |
| 7/14/2020 | 17:46 | PR Newswire (US) | GSK announces FDA advisory committee votes in favour of.. |
| 7/14/2020 | 08:19 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
Glaxosmithkline Discussion Forums - GSK
| Date | Time | Comments | Title |
|---|---|---|---|
| 5/18/2020 | 11:26 | - | Trump promises Cincinnati rally that US will end |
| 5/18/2020 | 09:29 | - | $GSK Democratic-run House approves its $3 trillion relief |
| 5/18/2020 | 09:19 | - | Here''s Why Investors Should Follow Sanofi $SNY and |
| 5/18/2020 | 09:00 | - | [b][b]**** BREAKING HIV $GSK <<<< Drug giant GSK |
| 3/25/2020 | 17:12 | - | [b]GSK[/b]-especially now in current market turmoil $35 looks |
| 10/29/2019 | 09:13 | - | Sci-B-Vac data is in December. That''s the drug |
| 10/25/2019 | 07:29 | - | $VBIV VBI Vaccines will collaborate with GlaxoSmithKline |
| 10/24/2019 | 14:25 | - | $VBIV VBI Vaccines will collaborate with GlaxoSmithKline ( |
| 10/23/2019 | 12:37 | - | $GSK and $VBIV VBI Vaccines teams up with |
| 10/23/2019 | 11:10 | - | Watch this one go up with Tesaro approval. |
Historical GSK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,609.20 | 1,656.20 | 1,567.80 | 1,590.11 | 7,971,348 | 41.20 | 2.56% |
| 1 Month | 1,643.60 | 1,677.40 | 1,567.80 | 1,630.88 | 7,370,960 | 6.80 | 0.41% |
| 3 Months | 1,651.80 | 1,742.40 | 1,561.60 | 1,655.93 | 8,673,239 | -1.40 | -0.08% |
| 6 Months | 1,806.00 | 1,857.00 | 1,328.60 | 1,613.03 | 11,071,136 | -155.60 | -8.62% |
| 1 Year | 1,618.00 | 1,857.00 | 1,328.60 | 1,656.74 | 9,792,343 | 32.40 | 2.0% |
| 3 Years | 1,607.00 | 1,857.00 | 1,236.40 | 1,539.82 | 9,325,643 | 43.40 | 2.7% |
| 5 Years | 1,385.00 | 1,857.00 | 1,227.50 | 1,527.68 | 9,171,324 | 265.40 | 19.16% |
